Cargando…

Hepatic steatosis in patients with acromegaly

OBJECTIVE: Comorbid NAFLD is increasingly being diagnosed in patients with diabetes and nondiabetic endocrinopathies. The aim of this study was to assess hepatic steatosis noninvasively by transient elastography in patients with acromegaly. DESIGN: A cross‐sectional study including 22 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koutsou‐Tassopoulou, Andreani, Papapostoli‐Sklavounou, Ifigeneia, Krawczyk, Marcin, Friesenhahn‐Ochs, Bettina, Weber, Susanne N., Lammert, Frank, Stokes, Caroline S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775446/ https://www.ncbi.nlm.nih.gov/pubmed/31592448 http://dx.doi.org/10.1002/edm2.90

Ejemplares similares

Short-Term Hypocaloric High-Fiber and High-Protein Diet Improves Hepatic Steatosis Assessed by Controlled Attenuation Parameter
por: Arslanow, Anita, et al.
Publicado: (2016)

Hepatic Steatosis Index in Acromegaly: Correlation with Insulin Resistance Regardless of the Disease Control
por: Ciresi, Alessandro, et al.
Publicado: (2018)

A frequent variant in the human bile salt export pump gene ABCB11 is associated with hepatitis C virus infection, but not liver stiffness in a German population
por: Müllenbach, Roman, et al.
Publicado: (2012)

Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis
por: Chalasani, Sai, et al.
Publicado: (2020)

Altered Expression of Antimicrobial Peptides in the Upper Gastrointestinal Tract of Patients with Diabetes Mellitus
por: Linn, Oliver, et al.
Publicado: (2023)

Hepatic consequences of COVID-19 infection. Lapping or biting?
por: Portincasa, Piero, et al.
Publicado: (2020)

Sneaky side effects and ineffectiveness of an immunotherapy with ipilimumab in a case of metastatic melanoma
por: Krecké, Nathalie, et al.
Publicado: (2016)

Increased Circulating VAP-1 Levels Are Associated with Liver Fibrosis in Chronic Hepatitis C Infection
por: Kraemer, Marcel, et al.
Publicado: (2019)

Identification of Combined Genetic Determinants of Liver Stiffness within the SREBP1c-PNPLA3 Pathway
por: Krawczyk, Marcin, et al.
Publicado: (2013)

Vitamin D supplementation: less controversy, more guidance needed
por: Stokes, Caroline S., et al.
Publicado: (2016)

Steatosis and hepatitis C
por: Modaresi Esfeh, Jamak, et al.
Publicado: (2016)

Cancer and hepatic steatosis
por: Paternostro, R., et al.
Publicado: (2021)

Complement in Acute Liver Failure: The Right Timing to Give a Sincere Compliment
por: Weber, Susanne N., et al.
Publicado: (2021)

Synergistic and Detrimental Effects of Alcohol Intake on Progression of Liver Steatosis
por: Di Ciaula, Agostino, et al.
Publicado: (2022)

Computed Tomography Measurement of Hepatic Steatosis: Prevalence of Hepatic Steatosis in a Canadian Population
por: Wells, Malcolm M., et al.
Publicado: (2016)

MARC1 p.A165T variant is associated with decreased markers of liver injury and enhanced antioxidant capacity in autoimmune hepatitis
por: Janik, Maciej K., et al.
Publicado: (2021)

Acromegaly
por: Chanson, Philippe, et al.
Publicado: (2008)

Acromegaly
Publicado: (1932)

Acromegaly
por: Gibson, G. A.
Publicado: (1899)

Acromegaly
Publicado: (1890)

Inflammatory Mediators of Hepatic Steatosis
por: Hijona, Elizabeth, et al.
Publicado: (2010)

Effect of Vildagliptin on Hepatic Steatosis
por: Macauley, Mavin, et al.
Publicado: (2015)

Hepatic glucose utilization in hepatic steatosis and obesity
por: Keramida, Georgia, et al.
Publicado: (2016)

Nuclear Receptor Variants in Liver Disease
por: Müllenbach, Roman, et al.
Publicado: (2012)

TLR4 Deficiency Protects against Hepatic Fibrosis and Diethylnitrosamine-Induced Pre-Carcinogenic Liver Injury in Fibrotic Liver
por: Weber, Susanne Nicole, et al.
Publicado: (2016)

MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery
por: Kalinowski, Piotr, et al.
Publicado: (2022)

Changes in human hepatic metabolism in steatosis and cirrhosis
por: Schofield, Zoe, et al.
Publicado: (2017)

The impact of hepatic steatosis on portal hypertension
por: Semmler, Georg, et al.
Publicado: (2019)

Serum 25-hydroxyvitamin D levels and mortality risk in patients with liver cirrhosis: a protocol for a systematic review and meta-analysis of observational studies
por: Völker, Désirée, et al.
Publicado: (2019)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Hepatic steatosis and fibrosis: Non-invasive assessment
por: Karanjia, Rustam N, et al.
Publicado: (2016)

Hemodynamic changes in hepatic sinusoids of hepatic steatosis mice
por: Fan, Jing, et al.
Publicado: (2019)

Hepatitis C Virus (HCV) Infection and Hepatic Steatosis
por: Yoon, Eugene J., et al.
Publicado: (2006)

Noninvasive monitoring of liver fat during treatment with GLP‐1 analogues and SGLT‐2 inhibitors in a real‐world setting
por: Mittag‐Roussou, Vasiliki, et al.
Publicado: (2020)

Comparison of Liver Fat Indices for the Diagnosis of Hepatic Steatosis and Insulin Resistance
por: Kahl, Sabine, et al.
Publicado: (2014)

The Endothelium in Acromegaly
por: Maffei, Pietro, et al.
Publicado: (2019)

Management of acromegaly
por: Vasilev, Vladimir, et al.
Publicado: (2010)

Localized acromegaly
por: Palikhe, Gaurav, et al.
Publicado: (2012)

Acromegaly in pregnancy
por: Koshy, T. George, et al.
Publicado: (2012)

Essays on Acromegaly
Publicado: (1892)

Cannot write session to /tmp/vufind_sessions/sess_tinniabd2k812ftpb4g2lphcmb